电子废物:毒性和安全性测试的机制
Chukwuebuka Eze1, Mathieu Vinken1
1Entity of In Vitro Toxicology and Dermato-Cosmetology, Department of Pharmaceutical and Pharmacological Sciences, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.
FEBS open bio
|July 10, 2024
概括
电子废弃物 (电子废弃物) 的化学毒性在分子水平上不明. 新的方法方法为评估电子废物化学混合物的风险和改善生态系统监测提供了有希望的无动物战略.
科学领域:
- 环境毒理学环境毒理学
- 机械毒理学 机械毒理学
- 生态毒理学 生态毒理学
背景情况:
- 关于电子废物化学品毒性的信息是零碎的,特别是在细胞和分子层面.
- 电子废物回收的化学混合物的毒性和作用机制在很大程度上是未知的.
- 现有的毒性评估方法,特别是动物试验,面临复杂性和有效性的局限性.
研究的目的:
- 审查目前关于电子废物暴露的毒性机制的知识.
- 突出电子废物化学风险评估新方法方法 (NAM) 的潜力.
- 确定知识差距,并为基于效果的监测策略提出方向.
主要方法:
- 关于电子废物化学毒性的综合文献综述.
- 对毒性机制,器官特异性影响和生物体水平影响的最新知识的分析.
- 评估新方法方法 (NAM) 作为传统动物试验的替代方案.
主要成果:
- 电子废物化学混合物由于毒性数据碎片化,造成了大部分未知的风险.
- 对于理解新陈代谢途径和调解不良健康结果,NAMs显示出前景.
- 基于效果的监测策略,以机制为基础,对于准确的风险评估至关重要.
结论:
- 迫切需要更好地了解电子废物化学混合物的毒性和机制.
- 新的方法方法为毒性测试提供了一个科学上优越的,基于人类和无动物的替代方案.
- 推进基于机制的基于效果的监测对于有效的电子废物管理和生态系统保护至关重要.
更多相关视频
09:01A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
Published on: March 14, 2019
7.2K
04:53Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
Published on: May 26, 2023
896
相关概念视频
01:36Types of Toxins
1.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.7K
01:25Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K